SCHEMBL6401546

SCHEMBL6401546

CCC(c1cccc(O)c1)C(O)c1c(O)cccc1OP(=O)(O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 1/20 0.42
OPRM1 P35372 1/20 0.42
INPPL1 O15357 2/20 0.37
INPP5B P32019 2/20 0.37
INPP5A Q14642 2/20 0.37
ADRB1 P08588 2/20 0.37
ADRA1A P35348 2/20 0.37
HTR2A P28223 2/20 0.37
MIF P14174 1/20 0.37
HTR2B P41595 1/20 0.37
HIF1A Q16665 4/20 0.36
LMNA P02545 3/20 0.36
GALR3 O60755 1/20 0.36
ADRB2 P07550 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRB3 P13945 1/20 0.35
TSHR P16473 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6397441 0.89 SLC22A1 (0.41) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL6402761 0.88 ESR1 (0.44) OPRM1INPPL1INPP5BINPP5AADRA1A
SCHEMBL6403707 0.85 ADRB1 (0.41) INPPL1INPP5BINPP5AADRB1ADRA1A
SCHEMBL7613752 0.85 BCHE (0.40) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL6395967 0.83 OPRM1 (0.42) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL6397848 0.83 OPRM1 (0.42) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL6401542 0.83 SLC22A1 (0.44) SLC22A1OPRM1ADRB1ADRA1AHTR2A
SCHEMBL7622944 0.81 INPPL1 (0.41) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL7620790 0.81 INPPL1 (0.37) SLC22A1OPRM1INPPL1INPP5BINPP5A
SCHEMBL6401536 0.80 SLC22A1 (0.41) SLC22A1OPRM1ADRB1ADRA1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-6787528-B2 THERAPY FOR KIDNEY DISEASES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-09-07 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation PEERCE BRIAN E (US) 2002-09-19 US disclosed
US-6355823-B1 MEMBRANE SUBSTRATE PHOSPHATED FOR DRUGS FOR GASTROINTESTINAL DISORDERS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 SLC22A1 50/4885OPRM1 4522/4885INPPL1 82/4885
US-20020133036-A1 Inhibitors of intestinal apical membrane Na/phosphate co-transportation SLC10A2, SLC34A3, SLC34A1 SLC22A1 50/4885OPRM1 4563/4885INPPL1 85/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 SLC22A1 50/4885OPRM1 4522/4885INPPL1 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.